In previous studies [9,10], our team investigated the encapsulation of GRb1 into PLGA nanoparticles, demonstrating enhanced bioavailability and alleviating myocardial cell damage, consequently treating heart failure through the ROS/PPARα/PGC1α pathway. This evidence concerns the gene PIK3R1 and heart failure.